Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Genet Mol Res ; 12(4): 5433-41, 2013 Nov 11.
Artigo em Inglês | MEDLINE | ID: mdl-24301916

RESUMO

To investigate the effect of tert-butylhydroquinone (tBHQ) on scrotal heat-induced damage in mice testes, 8-week-old mice were divided into 6 groups and administered with or without tBHQ through diet (10 mg/g), intraperitoneal injection (100 mg/kg body weight), or intratestis injection (12.5 mg/kg body weight), respectively. After single scrotal heat exposure (42 °C for 25 min), trunk blood and testes were collected 48 h later. The testes from diet and intraperitoneal tBHQ-treated mice showed more compact interstitial cells and less germ cell loss in the seminiferous epithelium compared with their corresponding non-tBHQ groups. However, intratestis tBHQ treatment showed no marked difference relative to the non-treatment group. In addition, pre-treatment of tBHQ caused lower testosterone concentrations and reduced expression of cytochrome P450 17α-hydroxylase/17,20-lyase (CYP 17) compared to the corresponding non-tBHQ groups. The results indicated that scrotal heat-induced structural damage was partly prevented by pre-treatment of tBHQ, which could be used as an effective antioxidant for preventing scrotal heat-mediated male infertility.


Assuntos
Antioxidantes/farmacologia , Temperatura Alta/efeitos adversos , Hidroquinonas/farmacologia , Infertilidade Masculina/prevenção & controle , Testículo/efeitos dos fármacos , Animais , Antioxidantes/uso terapêutico , Hidroquinonas/uso terapêutico , Infertilidade Masculina/etiologia , Masculino , Camundongos , Espermatozoides/efeitos dos fármacos , Esteroide 17-alfa-Hidroxilase/genética , Esteroide 17-alfa-Hidroxilase/metabolismo , Testículo/metabolismo , Testículo/patologia , Testosterona/sangue
2.
Braz. j. med. biol. res ; 43(9): 843-852, Sept. 2010. ilus, tab
Artigo em Inglês | LILACS | ID: lil-556853

RESUMO

To determine if Butea superba Roxb., a traditional Thai male potency herb, has androgenic activity in 60-day-old male Wistar rats, we measured its effects on the pituitary-testicular axis and sex organs. Intact and orchidectomized adult male rats were subdivided into five groups (10 rats/group): distilled water, Butea superba (BS)-10, BS-50, BS-250, and testosterone propionate (TP). They received 0, 10, 50, and 250 mg·kg body weight-1·day-1 BS in distilled water by gavage and 6 mg·kg body weight-1·day-1 TP sc, respectively, during the 30-day treatment period. Blood was collected every 15 days and luteinizing hormone (LH), follicle-stimulating hormone (FSH) and testosterone were measured. Changes of weight and histological appearance of sex organs were determined at the end of the 30-day treatment and 15-day post-treatment periods. TP treatment reduced serum FSH and LH levels and significantly increased the weight of the seminal vesicles and epididymis, in accordance with histopathological changes, in both intact and orchidectomized rats. No changes in serum testosterone, LH, and FSH levels were observed in any of the intact rats treated with BS, but a significant increase in seminal vesicle weight was observed only in the BS-250 group. Although a significant reduction in serum LH was detected in the BS-50 and BS-250 groups of orchidectomized rats, no significant change in weight or histology of sex organs was observed. Thus, we conclude that B. superba needs endogenous testosterone to work synergistically to stimulate the accessory sex organ of intact animals and can potentially exhibit an LH reduction effect in orchidectomized animals.


Assuntos
Animais , Masculino , Ratos , Butea/química , Hormônio Foliculoestimulante/sangue , Hormônio Luteinizante/sangue , Extratos Vegetais/farmacologia , Testosterona/sangue , Hormônio Luteinizante/efeitos dos fármacos , Orquiectomia , Tamanho do Órgão/efeitos dos fármacos , Hipófise/efeitos dos fármacos , Radioimunoensaio , Ratos Wistar , Glândulas Seminais/efeitos dos fármacos , Testículo/efeitos dos fármacos , Propionato de Testosterona/farmacologia
3.
Braz J Med Biol Res ; 43(9): 843-52, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20721473

RESUMO

To determine if Butea superba Roxb., a traditional Thai male potency herb, has androgenic activity in 60-day-old male Wistar rats, we measured its effects on the pituitary-testicular axis and sex organs. Intact and orchidectomized adult male rats were subdivided into five groups (10 rats/group): distilled water, Butea superba (BS)-10, BS-50, BS-250, and testosterone propionate (TP). They received 0, 10, 50, and 250 mg·kg body weight(-1)·day(-1) BS in distilled water by gavage and 6 mg·kg body weight(-1)·day(-1) TP sc, respectively, during the 30-day treatment period. Blood was collected every 15 days and luteinizing hormone (LH), follicle-stimulating hormone (FSH) and testosterone were measured. Changes of weight and histological appearance of sex organs were determined at the end of the 30-day treatment and 15-day post-treatment periods. TP treatment reduced serum FSH and LH levels and significantly increased the weight of the seminal vesicles and epididymis, in accordance with histopathological changes, in both intact and orchidectomized rats. No changes in serum testosterone, LH, and FSH levels were observed in any of the intact rats treated with BS, but a significant increase in seminal vesicle weight was observed only in the BS-250 group. Although a significant reduction in serum LH was detected in the BS-50 and BS-250 groups of orchidectomized rats, no significant change in weight or histology of sex organs was observed. Thus, we conclude that B. superba needs endogenous testosterone to work synergistically to stimulate the accessory sex organ of intact animals and can potentially exhibit an LH reduction effect in orchidectomized animals.


Assuntos
Butea/química , Hormônio Foliculoestimulante/sangue , Hormônio Luteinizante/sangue , Extratos Vegetais/farmacologia , Testosterona/sangue , Animais , Hormônio Luteinizante/efeitos dos fármacos , Masculino , Orquiectomia , Tamanho do Órgão/efeitos dos fármacos , Hipófise/efeitos dos fármacos , Radioimunoensaio , Ratos , Ratos Wistar , Glândulas Seminais/efeitos dos fármacos , Testículo/efeitos dos fármacos , Propionato de Testosterona/farmacologia
4.
J Antimicrob Chemother ; 63(2): 337-9, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19038979

RESUMO

OBJECTIVES: The antifungal activity of curcumin was evaluated against 23 fungi strains and its in vitro inhibitory effect on the adhesion of Candida species to human buccal epithelial cells (BEC) was also investigated. METHODS: The antifungal susceptibility was evaluated by broth microdilution assay following the CLSI (formerly the NCCLS) guidelines. The inhibitory effect of curcumin on the cell adhesion was performed with Candida species and BEC. RESULTS: Paracoccidioides brasiliensis isolates were the most susceptible to curcumin while the growth of Aspergillus isolates was not affected. Curcumin was much more efficient than fluconazole in inhibiting the adhesion of Candida species to BEC, particularly those strains isolated from the buccal mucosa of AIDS patients. CONCLUSIONS: The lack of antifungal compounds with reduced side effects highlights the importance of studying natural products for this purpose. Curcumin was a more potent antifungal than fluconazole against P. brasiliensis, the causal agent of the neglected disease paracoccidioidomycosis. Curcumin dramatically inhibited the adhesion of Candida species isolated from AIDS patients to BEC, demonstrating that curcumin is a promising lead compound that warrants further investigation into its therapeutical use in immunocompromised patients.


Assuntos
Antifúngicos/farmacologia , Curcumina/farmacologia , Fungos/efeitos dos fármacos , Adesão Celular/efeitos dos fármacos , Células Cultivadas , Células Epiteliais/microbiologia , Humanos , Testes de Sensibilidade Microbiana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA